Powered by RND
PodcastsSciencePharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive Podcast
Pharmaceutical Executive
Latest episode

Available Episodes

5 of 207
  • Pharmaceutical Executive Daily: Why DSCSA Compliance is Only The Beginning
    In today’s Pharmaceutical Executive Daily, we cover the FDA’s approval of Johnson & Johnson’s Simponi for pediatric ulcerative colitis, why DSCSA compliance is only the beginning of pharma supply chain modernization, and the agency’s approval of Jascayd for idiopathic pulmonary fibrosis.
    --------  
    2:37
  • Pharmaceutical Executive Daily: Amgen Launches New Direct-To-Consumer Platform
    In today’s Pharmaceutical Executive Daily, we explore why medical AI success depends on more than algorithms, Amgen’s launch of its new direct-to-consumer platform AmgenNow, and AstraZeneca’s multi-target research partnership with Algen.
    --------  
    3:00
  • Pharmaceutical Executive Daily: FDA Lifts Clinical Hold on NUZ-001
    In today’s Pharmaceutical Executive Daily, we cover the FDA lifting its clinical hold on Neurizon Therapeutics’ lead program Nuz-001, the agency’s export ban on Sun Pharma’s Halol facility, and new insights on how small biotechs can better navigate regulatory and market complexities.
    --------  
    2:56
  • Pharmaceutical Executive Daily: Updated Vaccine Recommendations
    Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry. In today’s Pharmaceutical Executive Daily, we cover lessons from FDA complete response letters shaping CMC strategy in cell and gene therapy, Takeda’s decision to discontinue its cell therapy research programs, and the CDC’s latest update to COVID-19 vaccination recommendations.
    --------  
    2:40
  • Pharmaceutical Executive Daily: FDA's new Fast-Track Review
    In today’s Pharmaceutical Executive Daily, we cover the FDA’s new fast-track review program for U.S.-made generics, Novartis’ FDA approval of Rhapsido for chronic spontaneous urticaria, and Halozyme’s $750 million acquisition of Elektrofi to strengthen drug delivery innovation.
    --------  
    2:49

More Science podcasts

About Pharmaceutical Executive

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. 
Podcast website

Listen to Pharmaceutical Executive, Shocked and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features
Social
v7.23.9 | © 2007-2025 radio.de GmbH
Generated: 10/10/2025 - 3:05:10 PM